Medifast controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2012
False-advertising settlement involving Medifast 5 & 1 claims
Jason Pharmaceuticals, a Medifast subsidiary, paid a $3.7 million civil penalty following action by the Federal Trade Commission and the United States Department of Justice. Regulators challenged advertising that said users could lose two to five pounds per week, finding the claims unsupported by a reasonable scientific basis. The settlement required future claims to have support from at least one human clinical study.